Kidney transplantation in adults | 合法醫療器材資訊網

Read More

由 AL Robles-Piedras 著作 · 2009 · 被引用 7 次 — Tacrolimus, a macrolide immunosuppressant agent, is indicated for the prophylaxis of organ rejection in patients receiving allogenic liver or kidney ... Read More

由 HY Jung 著作 · 2020 · 被引用 1 次 — TAC trough levels after 1 year post-transplant remained at a similar level until the fifth year after kidney transplantation and were not directly ... Read More

由 AK Israni 著作 · 2013 · 被引用 53 次 — In general, TAC trough levels of 8–15 ng/mL were targeted in months 0–3 post-​transplant and targets of 5–10 ng/mL in months 4–6, as per the ... Read More

由 S Yin 著作 · 2019 · 被引用 3 次 — In this study, we found that tacrolimus trough levels during the first month were associated with AR and infection after kidney transplantation. We ... Read More

由 HY Jung 著作 · 2019 · 被引用 9 次 — INTRODUCTION · Tacrolimus (TAC) is a calcineurin inhibitor (CNI) widely used to prevent acute rejection after kidney transplantation (KT). Read More

Side effects include gum hypertrophy, hirsuitism, renal impairment and hypertension. Tacrolimus is also monitored by trough levels, and again, each patient will ... Read More

由 K Hardinger 著作 · 被引用 1 次 — Although an adequate level of immunosuppression is required to dampen ... A discussion of induction therapy in kidney transplantation is presented separately. ... Randomized trial of tacrolimus (Prograf) in combination with  Read More

由 B Banas 著作 · 2020 · 被引用 2 次 — In a meta-analysis of 3 major studies including mostly Caucasian patients, Ekberg et al recommended optimal maintenance target tacrolimus trough levels < 10 ng/ ... Read More